Patent details

Basic Information

Publication number:

EP3210974

PCT Application Number:

JP2015079689

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP158520387

PCT Publication Number:

WO2016063906

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

PRODRUG OF ROFLUMILAST

French Title of Invention:

PROMÉDICAMENT DE ROFLUMILAST

German Title of Invention:

PRODRUG VON ROFLUMILAST

SPC Number:

Dates

Filing date:

21/10/2015

Grant date:

29/01/2020

EP Publication Date:

30/08/2017

PCT Publication Date:

28/04/2016

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

29/01/2020

EP B1 Publication Date:

29/01/2020

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

21/10/2020

Expiration date:

21/10/2035

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

22/01/2020

 

 

Name:

Hisamitsu Pharmaceutical Co., Inc.

Address:

408, Tashirodaikan-machi, Tosu-shi, Saga 841-0017, Japan (JP)

Inventor

1

Name:

ATARASHI, Kenji

Address:

Japan (JP)

2

Name:

YASUKOCHI, Takashi

Address:

Japan (JP)

3

Name:

TAKADA, Yasunori

Address:

Japan (JP)

4

Name:

YOKOTA, Shinichi

Address:

Japan (JP)

5

Name:

SUZUKI, Motohiro

Address:

Japan (JP)

6

Name:

SONOBE, Atsushi

Address:

Japan (JP)

Priority

Priority Number:

2014217205

Priority Date:

24/10/2014

Priority Country:

Japan (JP)

Classification

IPC classification:

A61K 31/44; A61P 11/00; A61P 43/00; C07D 213/75;

Publication

European Patent Bulletin

Issue number:

202005

Publication date:

29/01/2020

Description:

Grant (B1)

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages